LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer
Abstract Objective LAMA3 is a widely studied methylated gene in multiple tumors, but the relationship between chemotherapy resistance in ovarian cancer is unclear. In this study, LAMA3 methylation was predicted by bioinformatics, and the ability of LAMA3 methylation to predict the chemotherapy resis...
Main Authors: | Li-yuan Feng, Yong-zhi Huang, Wei Zhang, Li Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13048-021-00807-y |
Similar Items
-
Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer
by: Li-yuan Feng, et al.
Published: (2020-03-01) -
The role of DNA methylation in ovarian cancer chemoresistance: A narrative review
by: Kaiyang Song, et al.
Published: (2023-05-01) -
DNA methylation subtypes for ovarian cancer prognosis
by: Lili Yin, et al.
Published: (2021-03-01) -
DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers
by: Nicole Gull, et al.
Published: (2022-07-01) -
DNA methylation characteristics associated with chemotherapy resistance in epithelial ovarian cancer
by: Changling Duan, et al.
Published: (2024-03-01)